Showing results (281-290 of 380) with videos related to
Sort By:
Pageof 38
Panminerva Medica|November 24, 2011
Effects of elastic compression on hypomobility edema and fibrinolysis activation in multiple sclerosisG Arpaia, P M Bavera, D Caputo, et al.Panminerva Medica|May 15, 2015
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry studyP Rodriguez, G Belcaro, M Dugall, et al.Phytotherapy Research : PTR|January 30, 2013
Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndromeG Belcaro, U Cornelli, R Luzzi, et al.Journal of the National Cancer Institute. Monographs|May 4, 2023
Imaging modalities for measuring body composition in patients with cancer: opportunities and challengesUrvi A Shah, Tarah J Ballinger, Rusha Bhandari, et al.International Angiology : a Journal of the International Union of Angiology|December 19, 2014
Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progressionG Belcaro, E Ippolito, M Dugall, et al.Minerva Cardioangiologica|July 15, 2009
LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathyM R Cesarone, G Belcaro, M G Grossi, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 16, 2002
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trialL Incandela, G Belcaro, S Renton, et al.World Journal of Urology|September 26, 2025
Diagnostic accuracy of biparametric vs. multiparametric MRI for clinically significant prostate cancerNicholas A Pickersgill, Alex L Shiang, Joel M Vetter, et al.Angiology|January 29, 2005
HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry studyM R Cesarone, G Belcaro, L Pellegrini, et al.The Journal of Biological Chemistry|December 17, 2021
Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanomaMichael D Onken, Sarah E Noda, Kevin M Kaltenbronn, et al.Pageof 38